Concepedia

Joanna Parkinson

JP

14

Publications

365

Citations

13

H-Index

2011

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

AstraZeneca (Poland)

AstraZeneca (Australia)

Joanna Parkinson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and pharmacokinetics.

ORCID

Top concepts

Publications per year

2011–2024

14

Publications

14

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial

Austin G. Stack, Nalina Dronamraju, Joanna Parkinson et al. · American Journal of Kidney Diseases · 2020 · 68 citations · Full text

Parameter Identifiability of Fundamental Pharmacodynamic Models

David Janzén, Linnéa Bergenholm, Mats Jirstrand et al. · Frontiers in Physiology · 2016 · 47 citations · Full text

Translational pharmacokinetic–pharmacodynamic modeling of QTc effects in dog and human

Joanna Parkinson, Sandra A. G. Visser, Philip Jarvis et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 39 citations

, , +8

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study

Austin G. Stack, David Han, Ronald Goldwater et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 37 citations · Full text

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease

Viknesh Selvarajah, Darren Robertson, Lars Hansen et al. · Kidney International · 2024 · 26 citations · Full text

Rows per page

1–5 of 14